Application of Gene Therapy in Hemophilia.

Hu, Yue-Fen; Fang, Yun-Hai; Lai, Yong-Rong; Feng, Xiao-Qin; Xu, Shu-Qian

Hu, Yue-Fen; Fang, Yun-Hai; Lai, Yong-Rong; Feng, Xiao-Qin; Xu, Shu-Qian.

Affiliation

Hu YF; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250014, China.
Fang YH; Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan, 250014, China.
Lai YR; Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Feng XQ; Nanfang Hospital, Southern Medical University, Guangzhou, 510000, China.
Xu SQ; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250014, China. shuqian.xu@email.sdu.edu.cn.

Curr Med Sci ; 42(5): 925-931, 2022 Oct.

Article de En | MEDLINE | ID: mdl-36260269

Sujet(s)
Mots clés

CRISPR-Cas9; application; gene therapy; hemophilia

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Hémophilie A Limites: Humans Langue: En Journal: Curr Med Sci Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google